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Introduction
The interoceptive cues induced by a drug can come to 
guide behavior. The most widely studied example of this be-
havioral control is the operant drug discrimination task. In 
this task, the drug state, referred to as a discriminative stim-
ulus (SD), signals that a response will be reinforced. The ab-
sence of drug cues nonreinforcement of the same response 
(Colpaert 1986). Nicotine, the primary addictive constituent 
of tobacco, can serve as an SD in human and nonhuman ani-
mals. For example, rats can learn that one response, left-le-
ver presses, will be reinforced with a food pellet when nic-
otine (0.4 mg/kg, s.c.) is administered before the session; 
an alternative response (pressing right lever) has no conse-
quence. In contrast, when saline is administered, the right-
lever press will be reinforced (Stolerman 1989). In this two-
lever discrimination task, nicotine comes to prompt most-
ly left-lever pressing. Conversely, nicotine can also be con-
sidered a signal for nonreinforcement for right-lever press-
ing (SΔ) resulting in inhibition of responding (Honig et al. 
1963). Troisi (2003) recently showed that nicotine could 
function only as an SΔ. In this one-lever drug discrimination 
task, responding was reinforced on a variable interval 1-min 
schedule on saline sessions; nicotine (0.2 mg/kg, i.p.) occa-
sioned nonreinforcement. Responding was withheld only in 
the nicotine state.
There is a substantial literature on nicotine as an SD in 
this operant drug discrimination task. In contrast, there is 
relatively little research examining the cueing effects of nic-
otine in a Pavlovian discrimination task. Arguably, in a Pav-
lovian conditioning task, a positive feature is the procedural
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Abstract: Rationale  Pavlovian feature negative discriminations have been widely used to understand inhibitory conditioning 
processes using exteroceptive stimuli. Comparatively little is known about inhibitory conditioning processes using a drug state 
as a negative feature. A negative feature signals that presentation of a conditional stimulus (CS) will not be paired with an 
unconditioned stimulus. Objectives:  The present research examined whether nicotine served as a negative feature and started 
characterizing its properties. Methods and results:  In acquisition, rats received intermixed saline and nicotine (0.4 mg/kg, 
base) sessions. On saline sessions, a 15-s light CS was paired with 4-s access to sucrose; the CS was presented on nicotine 
sessions, but sucrose was withheld. The discrimination was acquired with more goal tracking during the CS on saline sessions. 
Nicotine’s inhibition of this conditioned response (CR) was sensitive to nicotine dose (ED50=0.225) and injection to testing 
interval (CR returned at 200 min). Mecamylamine pretreatment, but not hexamethonium, produced a loss of inhibitory control 
by nicotine suggesting a role for central nicotinic acetylcholine receptors. Amphetamine, bupropion, arecoline, and chlordi-
azepoxide, but not caffeine, substituted for the nicotine feature. However, in locomotor tests, amphetamine and bupropion 
increased activity; arecoline and chlordiazepoxide decreased activity. For this reason, the motor effects of these ligands could 
not be dissociated from substitution via shared stimulus properties. Conclusions:  This feature negative task provides a pre-
clinical model for studying how drug states inhibit responding, although identifying the process(es) mediating CR inhibition 
will require further research.
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equivalent to an SD (cf. Davidson et al. 1988). A drug state 
is a positive feature if it sets the occasion upon which anoth-
er stimulus (i.e., conditional stimulus or CS) is paired with 
an unconditioned stimulus (US). We have shown that nico-
tine serves as a positive feature in an appetitive discrimina-
tion task with rats (Palmatier et al. 2004, 2005; Sanderson 
et al. 2003). In that research, a brief light CS was present-
ed several times in daily 20-min sessions. On nicotine ses-
sions (0.4 mg/kg), the light CS was followed by 4-s access 
to a sucrose solution in a dipper receptacle. No sucrose was 
delivered if saline was administered. Differential control by 
the CS of head entries into the dipper, hereafter termed goal 
tracking, is a widely used measure of Pavlovian conditioned 
responding (Bouton and Sunsay 2003; Delamater 1995; Re-
scorla 1999) and refers to a rat’s tendency to search plac-
es where rewards have occurred (Boakes 1977; Farwell and 
Ayres 1979). The light CS evoked more goal tracking in the 
nicotine state than the saline state, indicating that nicotine 
served as a positive feature [see Parker et al. 1994 and Mill-
er et al. 2002 for examples of Pavlovian drug discrimina-
tions using pigeon sign tracking (autoshaping) with metha-
done or phencyclidine as a drug feature].
Drug states may also function as a negative feature in 
a Pavlovian discrimination task. A negative feature signals 
that the CS will not be paired with the US (cf. SΔ). For ex-
ample, Troisi and Akins (2004) using a sexual conditioning 
task reported that cocaine (10 mg/kg) served as a negative 
feature. That is, male quail were administered either cocaine 
or saline. On saline sessions, entrance of a wood block (the 
CS) into the apparatus signaled copulatory opportunity with 
a female (the US). On cocaine sessions, the wood block CS 
was presented but was not followed by the US. Condition-
ing was evidenced by male quail approaching the vicinity 
where the CS was presented on past conditioning trials only 
in the saline state (i.e., sign tracking). 
Maes and Vossen (1997) attempted to establish amphet-
amine (0.5 mg/kg) or midazolam (0.1 mg/kg) as a negative 
feature in rats using a goal-tracking task similar to the one 
described earlier (cf. Palmatier et al. 2005). In the Maes 
and Vossen study, the drug state signaled that 30-s illumi-
nation of a light within a food magazine was not followed 
by a food pellet; in the saline state, the same light CS was 
followed by food. After training (i.e., 20 reinforced and 20 
nonreinforced light trials), extinction tests were conducted 
to assess stimulus control. Relative to saline, neither am-
phetamine nor midazolam prompted less goal tracking dur-
ing the light CS indicating that neither drug served as a neg-
ative feature for withholding goal tracking. 
For several reasons, this failure probably does not refl ect a 
fundamental difference between sign tracking vs goal track-
ing, quail vs rats, copulatory opportunity vs food, or cocaine 
vs amphetamine or midazolam. First, nicotine can serve as 
an SΔ for food-reinforced lever pressing in rats (Troisi 2003). 
Second, drug states can serve as negative features in aversive 
Pavlovian conditioning tasks. For example, Jaeger and Mu-
cha (1990) pretreated rats with fentanyl (0.04 mg/kg, s.c.) or 
saline before access to a novel taste (the CS). On saline ses-
sions, the taste CS was followed by an illness-inducing in-
jection of LiCl (the US). On fentanyl sessions, taste was not 
followed by LiCl. Rats consumed more of the taste CS on 
drug than saline sessions indicating that fentanyl served as a 
negative feature inhibiting the avoidance CR. Third, nicotine 
can serve as a CS− in a Pavlovian drug discrimination task 
(Besheer et al. 2004). In that study, saline signaled intermit-
tent access to liquid sucrose (CS+); nicotine (0.4 mg/kg, s.c.) 
signaled the absence of sucrose (CS−). In contrast to the drug 
feature research, there were no discrete cues in either session 
type. Rats learned the discrimination with more goal tracking 
in saline than in nicotine sessions. 
The main goal of the present research was to determine 
whether nicotine could serve as a negative feature in a goal-
tracking task. Such a demonstration is important. The bulk 
of research on drug states has focused on facilitation of be-
havior. Development of a feature negative task would pro-
vide the fi eld with a tool for studying how drug states in-
hibit conditioned responding. Because nicotine functioned 
as a negative feature, an additional goal was to provide an 
initial characterization (duration, antagonism, substitution, 
generalization) of nicotine in this role. In substitution tests, 
arecoline, a muscarinic acetylcholine receptor agonist, and 
chlordiazepoxide (CDP), a GABAA agonist, were selected 
because their SD properties differ from nicotine (Schechter 
and Rosecrans 1972; Stolerman et al.  1984). Nicotine has 
stimulant properties in rats (Bevins and Palmatier 2003); 
thus, caffeine and D-amphetamine were selected for their 
stimulant actions. Finally, bupropion was of interest given 
its use as a smoking cessation aid (Zyban) and recent evi-
dence showing substitution for the cueing effects of nico-
tine (Besheer et al. 2004; Young and Glennon 2002).
Materials and methods
Animals   Twenty-one male Sprague–Dawley rats from 
Harlan (Indianapolis, IN) were housed separately in poly-
carbonate tubs lined with wood shavings in a temperature- 
and humidity-controlled colony. Water was available con-
tinuously in the colony, but access to chow was restricted 
so that rats were maintained at 85% of their free-feeding 
weight (375±8 g). This 85% weight was adjusted by 2 g ap-
proximately every 30 days. All experimental sessions were 
conducted during the light portion of a 12:12 h light/dark 
cycle. Experimental protocols were approved by the Univer-
sity of Nebraska-Lincoln IACUC and followed the “Guide 
for the Care and Use of Laboratory Animals” (National Re-
search Council 1996). 
Apparatus   Each of the seven conditioning chambers 
(ENV-008CT; Med Associates, Georgia, VT) had clear 
polycarbonate ceiling, front wall, and back wall; sidewalls 
were aluminum. On the bottom center of one sidewall was a 
5.2×5.2 cm opening to a recessed dipper receptacle. Sucrose 
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solution (26% w/v) was delivered via a 0.1-ml cup attached 
to a dipper arm. An infrared unit, located 1.2 cm within the 
receptacle and 3 cm from the fl oor, detected head entries. 
Mounted above (6 cm) and to either side of the top edge of 
the dipper were two white cue lights (28 V, 100 mA). Illu-
mination of the lights for 15 s served as the CS. Each cham-
ber was housed in a sound-attenuating cubicle fi tted with a 
fan to provide airfl ow and masking noise. A personal com-
puter with Med Associates interface and software controlled 
stimulus events and recorded dipper entries. Activity was 
measured in chambers made of white PVC pipe (30.5-cm 
diameter). Each chamber was divided into four equal sec-
tions by two infrared units positioned 4 cm above the wire 
mesh fl oor. Activity was defi ned as the number of beam 
breaks recorded by a computer. 
Drugs   (−)Nicotine hydrogen tartrate, mecamylamine hy-
drochloride, hexamethonium sulfate, arecoline hydrochlo-
ride, D-amphetamine sulfate, chlordiazepoxide hydrochlo-
ride, bupropion hydrochloride, and caffeine anhydrous (Sig-
ma, St. Louis, MO) were dissolved in saline (0.9% NaCl). 
Nicotine was brought to a pH of 7.0±0.2 with a dilute NaOH 
solution. Nicotine, arecoline, mecamylamine, and hexame-
thonium were administered via subcutaneous (s.c.) injection 
at a volume of 1 ml/kg. All other compounds except caffeine 
were injected intraperitoneally (i.p.) at the same volume; caf-
feine was administered i.p. at 2 ml/kg. Nicotine doses are ex-
pressed as the base form; all other drug doses are expressed 
as the salt form. Injection route, as well as injection to place-
ment interval and doses (see later), was based on past nico-
tine drug discrimination research (cf. Palmatier et al. 2005; 
Stolerman et al. 1984; Young and Glennon 2002). 
General procedures
Dipper training and acquisition   For 3 days (ca. 50 min/
day), rats were trained to access sucrose within 4 s. Sucrose 
deliveries were controlled by a probability function that 
began at 0.167 per 4 s and decreased to 0.05 per 4 s over 
three sessions. This training regime resulted in robust dip-
per-entry behavior for all rats. In acquisition, rats received 
a s.c. nicotine (0.4 mg/kg) or saline injection 5 min before 
the start of a session. On saline sessions, the offset of each 
of the eight 15-s light CS presentations was followed by 4-
s access to sucrose. Nicotine sessions were similar except 
CS offset was followed by a 4-s “empty interval” (i.e., no 
sucrose). Acquisition consisted of 8-day cycles that includ-
ed four nicotine and four saline sessions. Session order was 
randomly determined with the restriction that no more than 
two of a session type could occur consecutively in a cycle. 
Sessions lasted about 20 min. The time before onset of the 
fi rst CS varied from 90 to 180 s (mean 135 s) with time be-
tween sucrose offset and the next CS onset varying from 75 
to 165 s (mean 120 s). Rats received 12 nicotine and 12 sa-
line sessions before testing. 
Testing   Rats were assigned to one of two groups before 
testing: group 1 (n=7) or group 2 (n=14). Groups differed 
only in what variable was assessed on test days (see Fig. 1 
for a diagram of the methods). For testing, cycles were 
shifted from 8 to 7 days; each cycle included three nicotine 
and three saline training sessions followed by a test session. 
Training sessions were identical to those in acquisition, and 
data from these sessions were used to determine whether 
a rat met performance criteria for testing (see later). Rats 
that did not meet criteria remained in the home cage on the
Fig. 1  This shows a fl ow chart of the methods for each group. All rats received dipper training followed by Pavlovian drug discrimination 
in which nicotine (Nic) signaled the absence of reinforcement following presentation of the 15-s light CS (L–). The light CS was followed by 
4-s access to a sucrose solution (L+) on saline (Sal) sessions. For group 1 (n=7), antagonism of the nicotine negative feature was assessed 
before testing the effects of the injection to placement interval. For group 2 (n=14), a nicotine generalization function was obtained before 
substitution of various doses of the listed ligands. Testing of the locomotor effects of the listed ligands was conducted following comple-
tion of temporal generalization (group 1) or substitution (group 2). 
*Only a subset of rats from each group was tested (see main text for details)
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test day. During the 4-min test session, rats received a single 
presentation of the 15-s light CS; sucrose was withheld on 
test days. The time between the start of the test session and 
onset of the CS varied as in the acquisition phase.
Specifi c procedures: group 1
Antagonism   The 7-day testing cycle started immediate-
ly after acquisition training. On the test day, rats that met 
criteria were treated with the central and peripheral nico-
tinic acetylcholine receptor (nAChR) antagonist mecamyl-
amine (0.5 or 1 mg/kg; Martin et al. 1989), the peripheral 
nAChR antagonist hexamethonium (2.5 or 5 mg/kg; Asghar 
and Roth 1971), or saline s.c. 20 min before the start of the 
session. As in training, nicotine (0.4 mg/kg) was injected 
5 min before the test. Each rat was tested with each solution 
in random order. Upon completion of that order, a new ran-
dom order was tested. 
Injection to testing interval   Upon completion of the an-
tagonism tests, the 7-day cycle continued, but on the test day, 
rats were injected with the nicotine training dose and then 
placed in the test chamber after 0, 5, 50, 100, or 200 min 
had elapsed from injection. Each rat was tested at each in-
terval in random order. Upon completion of that sequence, 
a new random order was tested. Once both sequences were 
completed, one additional interval was tested. In that test, 
rats were injected with nicotine, immediately placed in the 
chamber, and the CS onset occurred 15 s after the start of 
the session rather than the typical 90–180 s. 
Specifi c procedures: group 2
Nicotine generalization   On the test day, rats that met 
criteria were tested with saline or one of six doses of nic-
otine (0.01, 0.03, 0.05, 0.1, 0.2, or 0.4 mg/kg). Nicotine 
was injected 5 min before the start of the 4-min test ses-
sion. Each rat was tested once with each solution in ran-
dom order. 
Substitution   Upon completion of generalization, sub-
stitution of the following ligands was assessed: arecoline 
(0.375, 0.75, 1.5 mg/kg), bupropion (5, 10, 20, 30 mg/kg), 
caffeine (5, 10, 30 mg/kg), CDP (2.5, 5, 10 mg/kg), or D-
amphetamine (0.125, 0.25, 0.5, 1 mg/kg). Arecoline was in-
jected s.c. 5 min before testing; the remaining ligands were 
injected i.p. 15 min before testing. A random order was gen-
erated at the start of substitution testing for each rat, but 
when an additional dose of a ligand was added due to pre-
liminary results, that dose was inserted randomly into the 
remaining sequence. One rat in group 2 displayed atypical 
behaviors in the home cage in this phase. It was given free 
access to food and did not continue in the experiment. Ac-
cordingly, data from this rat were excluded from analyses 
and graphs for this phase. 
Locomotor assessment
The locomotor effects of ligands used in substitution 
testing were assessed once rats fi nished in the discrimina-
tion task. First, rats were exposed to the locomotor chamber 
for 30 min on three consecutive days to reduce novelty-in-
duced activity. On the following day, each rat was exposed 
to the locomotor chamber for 10 min and then returned to 
the home cage. The assigned ligand was then administered, 
and the rat was returned to the chamber after the injection 
to placement interval used in substitution testing. Locomo-
tor activity was collected for 10 min. We analyzed and plot-
ted activity counts from the fi rst 4 min because this time re-
fl ects the duration of substitution tests. This procedure was 
repeated daily until all assigned ligands were tested. A sub-
set of rats from groups 1 and 2 (n=12) were tested with sa-
line, 0.4 mg/kg nicotine, 1 mg/kg amphetamine, 20 mg/kg 
bupropion, 10 mg/kg CDP, and 1.5 mg/kg arecoline. A dif-
ferent subset of rats (n=7) was tested with saline, 0.2 mg/kg 
nicotine, 10 and 30 mg/kg caffeine, and 0.75 mg/kg areco-
line. Each rat remained at its 85% weight and was assigned 
a unique drug order for testing.
Discrimination criteria and data analyses
Dipper entries were converted to elevation and dura-
tion scores. The elevation score was defi ned as the number 
of entries during the 15-s light CS minus the entries in the 
15-s interval immediately before CS onset (pre-CS period). 
The duration score was defi ned as the time the head was in 
the dipper during the CS minus the duration during the pre-
CS period. The elevation score served as the main depen-
dent measure because it allows comparison with previously 
published research on drug features (Palmatier et al. 2004, 
2005), and the data pattern was similar for each measure 
making presentation of duration scores redundant. We also 
analyzed the pre-CS dipper entry rates to determine whether 
baseline levels of dipper entries changed with tests. Before 
testing, each rat was required to meet two criteria. (1) The 
mean elevation or duration score for nicotine sessions were 
subtracted from corresponding saline sessions score. Test-
able performance was defi ned as a mean difference score 
≥ 3 for elevation score or a mean difference score ≥2 s for 
duration score. (2) A similar contrast was conducted on fi rst 
trial elevation and duration scores for the last nicotine and 
saline training sessions; the difference had to be positive 
(cf. Palmatier et al. 2004, 2005). 
When a rat was tested twice on the same variable (see 
group 1), a single value for analysis was derived by taking 
an average for each rat. Omnibus tests were one or two-way 
repeated measures analyses of variance (ANOVA). Post 
hoc comparisons prompted by a signifi cant F value used 
Tukey’s HSD tests to control for type I error rate. These 
comparisons were limited to contrasting each test value to a 
474                                                             Bevins, Wilkinson, Palmatier, Siebert, & Wiltgen
saline and/or nicotine comparison condition. Statistical sig-
nifi cance was declared using a two-tailed rejection region 
of 0.05 for all tests. The median effective dose (ED50) was 
calculated using linear regression on doses from the ascend-
ing limb of the dose-effect function. Locomotor activity for 
each test dose was compared to saline using t-tests.
Results
Acquisition: all rats   The feature negative discrimina-
tion was readily acquired with goal tracking in the saline 
state increasing across early sessions (Fig. 2). There was a 
main effect of Drug and Session (F’s≥21.32, p’s<0.001) and 
a signifi cant Drug×Session interaction [F(11,220)=21.82, 
p<0.001, MSE=1.55]. Elevation scores were signifi cantly 
different from session 2 to 12 [minimum mean difference 
(mmdhsd)=0.76]. For pre-CS dipper entries in the last two 
nicotine and two saline sessions, neither the Drug nor the 
Drug×Session interaction was signifi cant (F’s<1), indicat-
ing similar baseline levels of dipper entries (see Table 1).
Group 1: nAChR antagonism   Pretreatment with meca-
mylamine, but not hexamethonium, blocked nicotine’s abil-
ity to serve as a negative feature (Fig. 3a). The saline pre-
treatment data (leftmost bar) were included in each of the 
following ANOVAs. The ANOVA for hexamethonium was 
not signifi cant (F<1). In contrast, the ANOVA for mecamyl-
amine was signifi cant [F(2,12)=12.94, p=0.001, MSE=3.20] 
with both doses of mecamylamine increasing goal tracking 
relative to saline pretreated controls (mmdhsd=2.55). These 
nAChR antagonists did not affect dipper entry rates during 
the pre-CS period (F’s<1; see Table 1).
Injection to testing interval   Nicotine lost its function 
as a negative drug feature as time increased between nic-
otine injection and placement into the conditioning cham-
ber (Fig. 3b). The ANOVA was signifi cant [F(4,24)=15.85, 
p<0.001, MSE=3.14], with the 200-min interval differing 
from 5-min training delay (mmdhsd=2.83). Dipper entry 
rates during the pre-CS period did not vary signifi cantly as 
a function of test interval, [F(4,24)=1.63, p=0.20; Table 1]. 
Fig. 2  Mean elevation score (±1 SEM) for nicotine 
and saline sessions for all rats in the acquisition phase. 
Bracket with asterisk denotes signifi cant difference 
(p<0.05) between sessions 2 to 12
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The rightmost bar in Fig. 3b shows the additional test data 
in which rats received the light CS 15 s after nicotine and 
placement into the chamber. The elevation score and pre-CS 
dipper entries for this test delay did not differ statistically 
from the 5-min value (t’s<1). 
Group 2: nicotine generalization   Elevation scores 
increased as the dose of the nicotine feature was de-
creased from the 0.4-mg/kg training dose [F(6,78)=5.71, 
p<0.001, MSE=5.89; Fig. 4a]. The 0.03- to 0.1-mg/kg dos-
es were signifi cantly higher than the nicotine training dose 
(mmdhsd=2.67). Further contrasts revealed that goal tracking 
was signifi cantly lower than saline levels only at the 0.4-mg/
kg dose. The ED50 for the nicotine feature was 0.225 mg/kg. 
Dipper entry rates during the pre-CS period did not vary as a 
function of nicotine dose [F(6,78)=1.02, p=0.419; Table 2].
Substitution tests   Goal tracking decreased as the 
dose of amphetamine increased [F(3,36)=4.57, p=0.008, 
MSE=10.34], suggesting substitution for the nicotine fea-
ture. The 0.125–0.25 mg/kg amphetamine doses controlled 
more goal tracking than nicotine (mmdhsd=3.43; Fig. 4b). 
Only the 1-mg/kg dose of amphetamine differed signifi cantly 
from the saline comparison. The ED50 for amphetamine was 
0.562 mg/kg. Bupropion displayed a pattern similar to am-
phetamine [F(3,36)=16.77, p<0.001, MSE=6.55]. Elevation 
Fig. 3  a Mean elevation score (±1 SEM) 
for the nicotinic acetylcholine antagonism 
tests for rats in group 1. Saline (SAL), hexa-
methonium, and mecamylamine were ad-
ministered 20 min before the start of the 
test (15 min before nicotine). Asterisks de-
note signifi cant difference from saline pre-
treatment condition, p<0.05. b Mean eleva-
tion score for the temporal delay tests for 
rats in group 1. The rightmost bar is from 
a follow-up test in which rats were placed 
immediately into the chamber after nico-
tine injection and the light CS was tested 
15 s after placement. Asterisk denotes sig-
nifi cant difference from the training delay 
(5 min), p<0.05
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scores at the 5 and 10 mg/kg bupropion doses were signifi -
cantly higher than the nicotine comparison (mmdhsd=2.73). 
Elevation scores for the 10, 20, and 30 mg/kg bupropion 
doses were signifi cantly lower than saline. The ED50 for 
bupropion was 12.5 mg/kg. The ANOVA for arecoline was 
not signifi cant [F(2,24)=2.39, p=0.113; Fig. 4b]. Given the 
trend, this lack of effect was likely driven by the variability 
at the 0.375-mg/kg dose. The higher dose of CDP appeared 
to partially substitute for the nicotine feature [F(2,24)=7.36, 
p=0.003, MSE=6.15]. Goal tracking to all doses of CDP 
was signifi cantly higher than nicotine (mmdhsd=2.46). How-
ever, only the 10-mg/kg dose was signifi cantly lower than 
saline. We did not calculate an ED50 for CDP given that full 
substitution was not demonstrated. Caffeine (5–30 mg/kg) 
did not substitute for the nicotine feature (F<1). Dipper en-
tries during the pre-CS period were not signifi cantly altered 
by any of the drugs (F’s<1.6; Table 2).
Locomotor assessment   Relative to saline, nicotine 
(0.2 and 0.4 mg/kg) and caffeine (10 and 30 mg/kg) did 
not affect activity (p’s≥0.23; see Fig. 5). In contrast, am-
phetamine (1 mg/kg) and bupropion (20 mg/kg) signifi -
cantly increased activity above saline levels [t’s(12)≥5.08, 
p’s<0.001]. CDP (10 mg/kg) and both doses of arecoline 
(0.75 and 1.5 mg/kg) had locomotor suppressant effects 
(t’s>2.54, p’s<0.03).
Fig. 4  a Mean elevation score 
(±1 SEM) for the nicotine gen-
eralization tests from rats in 
group 2. Asterisks denote signifi -
cant difference (p<0.05) from 
the training dose of nicotine 
(0.4 mg/kg). Plus indicates a sig-
nifi cant difference from saline 
(SAL). b Mean elevation scores 
from the substitution tests for 
group 2. The upper solid line 
represents the average eleva-
tion score from the last saline 
session before the start of sub-
stitution testing. Dashed lines 
represent the SEM. Plus symbols 
indicate a signifi cant difference 
from this saline comparison. 
The lower solid line represents 
the average elevation score 
from the last nicotine session 
before the start of substitution 
testing. Dashed lines represent 
the SEM. Asterisks indicate a 
signifi cant difference from this 
nicotine comparison. These 
post hoc comparisons were 
only conducted if the overall 
ANOVA was signifi cant
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Fig. 5  Mean activity (±1 SEM) 
from the locomotor test for 
higher doses of ligands used 
during substitution testing. 
The average for the saline 
(Sal) condition includes the 19 
rats tested with saline. How-
ever, the 12 rats tested with 
0.4 mg/kg nicotine, 1 mg/kg 
amphetamine (Amp), 20 mg/
kg bupropion (Bup), 10 mg/
kg chlordiazepoxide (CDP), 
and 1.5 mg/kg arecoline were 
compared only to their activ-
ity with saline (i.e., paired t-
tests). Similarly, the seven rats 
tested with 0.2 mg/kg nicotine, 
10 and 30 mg/kg caffeine, and 
0.75 mg/kg arecoline were 
compared only to their saline 
activity. Each rat remained at 
its 85% weight and was as-
signed a unique drug order for 
testing. Asterisks denote signifi -
cant difference from its saline 
comparison, p<0.05
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Discussion
There are numerous demonstrations that exteroceptive 
stimuli such as a light or tone can serve as negative features 
in an appetitive discrimination task (e.g., Holland 1984; Re-
scorla 1989). Recently, Troisi and Akins (2004), using a sex-
ual conditioning task, extended this observation to an inter-
ceptive drug cue (cocaine) in male quail. The present study 
extends this research to rats with nicotine (0.4 mg/kg) as the 
negative feature. That is, the goal-tracking CR during the 
light CS was inhibited on nicotine sessions. This extension 
also includes a different appetitive US, as well as use of a 
continuous-trial procedure rather than a discrete-trial proce-
dure. This latter feature has the advantage of allowing sev-
eral presentations of the US and/or the CS in a single place-
ment into the apparatus. 
The fi nding that nicotine functions as a negative fea-
ture extends our previous research with nicotine as posi-
tive feature (Palmatier et al. 2004, 2005; Sanderson et al. 
2003). As a positive feature, nicotine signals light CS–su-
crose US pairings; saline signals nonreinforcement of the 
CS. We took nicotine’s control of goal tracking as evidence 
that nicotine functioned as a positive feature. Alternative-
ly, an unconditional effect of nicotine might have increased 
dipper entries during the light CS. This account assumes 
that the light is mildly excitatory from sucrose delivery on 
50% of the presentations and that nicotine acts on this exci-
tation to increase dipper entries. Previously, our enthusiasm 
for this account was decreased by the failure of amphet-
amine to substitute for the positive nicotine feature (Palma-
tier et al. 2005). The present study provides direct evidence 
against this unconditional effect account in that sucrose was 
still delivered on 50% of the light presentations, yet dipper 
entries to the light CS on nicotine sessions were very low. 
Conversely, nicotine has been shown to affect ingestive be-
haviors (e.g., Baettig et al. 1980). The previous feature posi-
tive research with nicotine strains an appetite suppression 
account of response inhibition for nicotine as a negative 
feature. That is, as a positive feature, nicotine prompted ro-
bust sucrose-seeking behavior even on the fi rst light presen-
tation of the session—before sucrose delivery (see Sander-
son et al. 2003, Fig. 3b). 
Pretreatment with the central and peripheral nAChR an-
tagonist mecamylamine restored the goal-tracking CR to 
the light CS on nicotine test sessions; hexamethonium, a pe-
ripheral nAChR antagonist, did not. This outcome suggests 
a role for central nervous system (CNS) nAChRs. The cue-
ing effects of nicotine, whether in a Pavlovian or operant 
procedure, appear to be mediated by central nAChRs. Pre-
vious research has shown a similar pattern of antagonism 
when nicotine served as a positive feature (Palmatier et al. 
2004), as a CS+ or CS− (Besheer et al. 2004), or as an SD 
(Stolerman et al. 1984). Nicotine as a negative feature also 
varied with time since administration. Goal tracking to the 
light CS increased as injection to test interval increased 
to 200 min. Loss of stimulus control with delays between 
100 and 200 min is similar to research with nicotine as an 
SD (Hirschhorn and Rosecrans 1974; Schechter and Mee-
han 1992), a CS+ (Besheer et al. 2004), or a positive fea-
ture (Palmatier et al. 2004). This result likely refl ects de-
creased brain levels of nicotine (Ghosheh et al. 1999) and 
is consistent with the conclusion that CNS processes me-
diate nicotine’s ability to serve as a negative feature. One 
surprising result poses a caveat to this conclusion. In gen-
eral, when the cueing effects of nicotine are tested within 
2–3 min after administration, there is a loss of stimulus con-
trol (Besheer et al. 2004; Palmatier et al. 2004; Pratt et al. 
1983). This outcome is often attributed to insuffi cient brain 
levels of nicotine (cf. Pratt et al. 1983). We did not fi nd this 
result in the present study. This suggests a possible periph-
eral component to nicotine as a negative feature. Notably, in 
previous research showing a loss of stimulus control, nico-
tine signaled availability of the reinforcer/US. In the present 
research, nicotine signals the absence of the US. Whether 
this difference is important will require establishing tempo-
ral-delay functions for nicotine as a CS− and as an SΔ. 
Conditional control by the negative nicotine feature was 
highly sensitive to shifts from the training dose (0.4 mg/
kg). When rats were tested with the 0.1-mg/kg dose of nic-
otine, goal tracking to the light CS was comparable to sa-
line levels. This sensitivity was also refl ected in an ED50 of 
0.225 mg/kg. This value is high relative to other discrim-
ination procedures: drug discrimination research using le-
ver pressing (Chance et al. 1977, ED50=0.087 mg/kg; Pratt 
et al. 1983, ED50=0.14 mg/kg), Pavlovian feature positive 
for an appetitive CS–US relation (Palmatier et al. 2005, 
ED50=0.054 mg/kg), and Pavlovian conditioning with nic-
otine as the CS+ (Besheer et al. 2004, ED50=0.113 mg/kg). 
As suggested earlier, perhaps this difference refl ects nico-
tine serving as a signal for the absence of the reinforcer vs a 
signal for its presence. 
The ability of nicotine to serve as a negative feature was 
not based on a nonspecifi c presence of drug vs absence of 
drug discrimination. If so, the discriminable 0.1 mg/kg nic-
otine dose would have maintained stimulus control (Bevins 
and Palmatier 2004; Stolerman et al. 1984). Also, caffeine 
at 10- and 30-mg/kg doses shown to have SD effects (Mum-
ford and Holtzman 1991) would have substituted for the nic-
otine feature. Neither result occurred. There is the possibil-
ity, however, that a higher dose of caffeine might substitute 
for nicotine in the present study. Mumford and Holtzman 
(1991) found that acquisition of an operant discrimination 
was faster with 56 than 10 mg/kg of caffeine; the pattern of 
substitution also differed between these doses suggesting 
different discriminative properties. 
In contrast to caffeine, amphetamine, bupropion, areco-
line, and CDP produced a loss of goal tracking during the 
light CS. Albeit suggestive of substitution, interpretation of 
this data pattern was complicated by the locomotor effects 
of the ligands. CDP (10 mg/kg) and arecoline (0.75 and 
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1.5 mg/kg) suppressed general activity. Thus, the decrease 
in CR to the light CS more likely refl ects suppression of ac-
tivity than shared stimulus properties with nicotine. In fu-
ture experiments, it will be of interest to test whether re-
peated administration of these locomotor suppressing li-
gands produces differential tolerance for the locomotor vs 
the negative feature effects of these ligands. 
Previous research with nicotine as a CS+ or as an SD has 
reported partial and/or full substitution with bupropion and 
amphetamine (Besheer et al. 2004; Chance et al. 1977; Young 
and Glennon 2002). For example, when nicotine served as 
a CS+, bupropion (20 mg/kg) evoked conditioned respond-
ing that was about 80% of that controlled by the 0.4 mg/kg 
nicotine training dose (Besheer et al. 2004). Substitution in 
that research was evidenced by an increase in goal tracking, 
whereas substitution for the negative nicotine feature in the 
present research was evidenced by a decrease in CR. This 
analysis suggests that the loss of CR to amphetamine and bu-
propion in the present research refl ects shared stimulus prop-
erties with the nicotine feature. However, we cannot elimi-
nate the possibility that the increase in activity seen in the lo-
comotor assay for amphetamine and bupropion did not inter-
fere with dipper entries during substitution. 
One other fi nding from the locomotor assay deserves dis-
cussion. In our hands, repeated exposure to nicotine (0.18–
0.42 mg/kg) increases rat’s locomotor activity relative to sa-
line—even in the fi rst 5 min (Bevins and Palmatier 2003; 
Bevins et al. 2005). This increase in activity was not seen 
at the 0.2- or 0.4-mg/kg dose in the present experiment. The 
most likely reason for this difference is the degree of chron-
ic experience with nicotine. The research showing locomo-
tor activation to nicotine tends to expose rats once per day 
for 8–10 days. In contrast, the rats in the present experiment 
were exposed to the training dose of nicotine at least 77 
times. In support of this interpretation, rats pre-exposed to 
nicotine (0.18 or 0.42 mg/kg) for only 27 days in the home 
cage had infl ated activity levels when subsequently treated 
with saline and tested in the same locomotor chambers used 
in the present experiment (Bevins and Palmatier 2003). 
Interpretation of the substitution test results is complicat-
ed by the fact that motor alterations (e.g., suppression, ste-
reotypy) and substitution for nicotine as a negative feature 
have the same data pattern—withholding of goal tracking. 
Dipper entries during the pre-CS period were so low (ca. 
1 per 15 s) that it does not provide a useful index of motor 
impairment. Also, locomotor activation on this baseline was 
not seen to amphetamine or bupropion. Soon, the chambers 
will be fi tted with infrared beams so that we also have a 
measure of motor activity. Perhaps this will help dissociate 
motor effects from substitution via shared stimulus proper-
ties. Until such time, we prefer this conservative and more 
parsimonious locomotor interpretation. That is, consider-
ing the ligands tested in substitution act on diverse neural 
processes (e.g., muscarinic acetylcholine receptor agonist, a 
GABAA agonist, dopamine and norepinephrine reuptake in-
hibitor, and dopamine agonist), one would be stretched to 
hypothesize a common neural process for substitution. 
The present feature negative protocol will be useful in 
elucidating the associative processes by which nicotine 
may inhibit conditioned responding. In more widely studied 
Pavlovian discrimination tasks, there have been numerous 
models suggested for these underlying inhibitory processes 
(Bouton and Nelson 1998; Brandon and Wagner 1998; Hol-
land 1992; Swartzentruber 1995). Figure 6 presents just two 
possible models. Conditioned responding in both models is 
the result of an excitatory association between light CS and 
sucrose US. Model 1, however, suggests that the negative 
nicotine feature alters the neurobiological processes medi-
ating the US representation. Rescorla (1979) described this 
inhibitory input as decreasing the ability of an excitatory 
CS to activate US processes (see Konorski 1948). Thus, the 
nicotine feature attenuates conditioned responding to the 
light because of a decreased “US threshold” for activation. 
Notably, this model predicts that the nicotine feature should 
pass retardation and summation tests of conditioned inhi-
bition (Rescorla 1969, 1979). In the retardation test, nico-
tine would be paired with the US after it was established 
as a negative feature; acquisition of conditioned responding 
to nicotine as a CS+ should be slower (retarded) relative to 
controls. In the summation test, nicotine’s ability to inhibit 
a CR should transfer to any excitatory CS that was paired 
with a comparable appetitive US.
Model 2, in contrast, assumes that nonreinforcement (i.e., 
extinction) of the light CS in nicotine sessions results in an 
inhibitory association with the US. However, the inhibitory 
association is conditional. This conditionality refl ects the ob-
servation that original excitatory training generally transfers 
to different contexts, yet extinction of that CS tends to be spe-
cifi c to the extinction context (Bouton and King 1983). Ac-
cordingly, model 2 includes an “and gate” (hatched circle) so 
that the inhibitory CS–US association does not affect condi-
tioned responding unless the nicotine feature is present (see 
Bouton and Nelson 1998 for related details). 
Fig. 6  Two possible models of how the nicotine feature could in-
hibit conditioned responding to the light CS. Models and graphic 
representation based on writings from Bouton and Nelson (1998), 
Holland (1992), and Rescorla (1979). An arrow denotes excitatory 
association, whereas a line with crossbar indicates an inhibitory as-
sociation. Hatched circle denotes an “and gate” allowing conditional 
operation of the inhibitory association by the nicotine feature.
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Importantly, the two models make some distinct predic-
tions. One notable prediction has to do with the retardation 
test described previously. In contrast to model 1, model 2 
does not necessarily predict slower acquisition of condi-
tioned responding to the nicotine feature if it is paired with 
the US after being trained as a negative feature. Another, 
and perhaps even more interesting, is that nicotine in model 
2 would retain its ability to serve as a negative feature for 
the light CS after this excitatory conditioning. Note that in 
model 2, an added excitatory association between nicotine 
and the US does not alter nicotine’s action on the inhibitory 
light CS–US association. In contrast, depending on theoreti-
cal perspective, subsequent excitatory training of the nico-
tine feature in model 1 would either result in a separate ex-
citatory association with the US or it would abolish and re-
place the nicotine–US inhibitory association with an excit-
atory association. Regardless, both predict signifi cant loss 
of nicotine’s ability to serve as a negative feature. 
We do not mean to imply in this closing discussion that 
the two models presented in Fig. 6 are the only possible in-
hibitory mechanisms. For example, nicotine could be act-
ing on the CS–US association (Holland 1992) or it could 
be part of a distinct confi gural cue (Pearce 1987). Rather, 
our point was to demonstrate the likely utility of this nega-
tive feature task and associated theorizing in leading to nov-
el experiments elucidating a potential inhibitory mechanism 
by which nicotine and other drugs of abuse (cf. Troisi and 
Akins 2004) might operate. Indeed, relative to other condi-
tioning processes, inhibitory learning processes have been 
essentially ignored in the drug conditioning fi eld. 
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